Active — Not RecruitingNot Applicable

A Study of the Life Changes Experienced by Patients With Pancreatic Cancer

United States55 participantsStarted 2020-06-05

Plain-language summary

The purpose of this study is to better understand what types of transitions people with pancreatic cancer face when they receive chemotherapy. Again, this study defines transition as a change in a life situation or a status that causes a change in a person's identity, role, behavior, or personal relationships. Examples of transitions include changes in sleeping habits, anxiety, employment, relationship with a higher power, and treatment goals.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients 18 years of age and older * primary language listed as English in electronic medical record * biopsy proven diagnosis of pancreatic cancer * within three months after initiating a chemotherapy regimen at the Rockefeller Outpatient Pavilion at MSKCC (patient may have previously received chemotherapy at an outside institution or may have received previous chemotherapy regimens at MSKCC). Exclusion Criteria: * previous history of cancer within the past five years, except for non-melanoma skin cancer, ductal carcinoma in situ breast cancer, and thyroid cancer.

What they're measuring

Extent of the change experienced by patients with pancreatic cancer

Timeframe: 4 to 6 weeks after baseline

Trial details

NCT IDNCT04427761

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06-05

View on ClinicalTrials.gov More Pancreatic Cancer trials